Published by Josh White on 21st February 2023
(Sharecast News) - Immunotherapy developer Scancell announced the completion of the monotherapy dose-finding arm of the phase 1 and 2 'ModiFY' clinical trial on Tuesday.
URL: http://www.digitallook.com/dl/news/story/33318129/...